Inoviv

Inoviv

Biotechnology

London, England 3,105 followers

Accelerating the Development of New Medicines with Targeted Proteomics

About us

Inoviv uses a novel technology platform based on targeted proteomics to support pharmaceutical companies with biomarker test development.

Website
http://www.inoviv.com
Industry
Biotechnology
Company size
11-50 employees
Headquarters
London, England
Type
Privately Held
Founded
2017
Specialties
Proteomics, Biomarker Discovery, Translational Biomarkers, Mass Spectrometry, Targeted Proteomics, Discovery Proteomics, Biomarkers, Precision Medicine, Proteomic Analysis, Proteome Profiling , Quantitative Proteomics, Liquid Chromatography Mass-Spectrometry (LC-MS), Post-Translational Modifications (PTMs), Quantitative Biomarkers, Clinical Proteomics, Immuno-Precipitation Mass Spectrometry (IP-MS), Proteins, LC-MS Proteomics, Proteomics Services, and Protein Identification

Locations

Employees at Inoviv

Updates

Similar pages

Browse jobs

Funding

Inoviv 3 total rounds

Last Round

Series unknown
See more info on crunchbase